– Theresa Satisfy Dr. Stanislaw Burzynski Stanislaw R. Burzynski, M.D., Ph.D., recognized doctor and biochemist-researcher internationally, pioneered the advancement and use of active peptides in diagnosing biologically, preventing and treating cancer. In 1967, at the young age of 24, Dr. Burzynski graduated from the Medical Academy in Lublin, Poland, with a M.D. Degree of distinction, finishing in his class of 250 initial. During the same year, he identified naturally happening peptides in our body which he concluded control cancers growth. He discovered that there is a marked scarcity of these peptides in cancers sufferers. Suzanne Somers, in her best-selling book, Knockout said, Dr.The breast cancer results grew out of Andreeff’s long-term study in mesenchymal stem cells, that may divide into one duplicate of themselves and one differentiated duplicate of a bone, muscle tissue, extra fat or cartilage cell. Andreeff shows these cellular mesenchymal stem cells house to wounds, including tumors, producing them potential carriers of cancers therapy. A significant cellular transition is necessary. Co-senior writer Sendurai Mani, Ph.D., associate professor in MD Anderson’s Section of Molecular Pathology and Co-Director of the Metastasis Analysis Center, is an professional on epithelial-to-mesenchymal changeover . About 85 % of most solid tumors begin in the liner of an organ, known as the epithelium.